Dexrazoxane (Alvogen Inc.)
Welcome to the PulseAid listing for the Dexrazoxane drug offered from Alvogen Inc.. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alvogen Inc. |
NON-PROPRIETARY NAME: | Dexrazoxane for Injection |
SUBSTANCE NAME: | DEXRAZOXANE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytoprotective Agent [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-09-01 |
END MARKETING DATE: | 0000-00-00 |
Dexrazoxane HUMAN PRESCRIPTION DRUG Details:
Item Description | Dexrazoxane from Alvogen Inc. |
LABELER NAME: | Alvogen Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/50mL) |
START MARKETING DATE: | 2017-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47781-578_6d0fbbe0-a755-ec98-0b79-8b3348ed0a5d |
PRODUCT NDC: | 47781-578 |
APPLICATION NUMBER: | ANDA207321 |
Other DEXRAZOXANE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: